Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

March 10, 2022

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2027

Conditions
Solid Tumors
Interventions
DRUG

ORIC-114

ORIC-114 oral daily

DRUG

Chemotherapy drug

21 days for up to 4 cycles

Trial Locations (42)

10016

RECRUITING

NYU Langone Health Perlmutter Cancer Center, New York

19104

RECRUITING

University of Pennsylvania, Philadelphia

20007

RECRUITING

Georgetown University, Washington D.C.

22031

RECRUITING

Next Oncology, Fairfax

27710

RECRUITING

Duke Cancer Institute, Durham

29303

RECRUITING

Spartanburg Regional Healthcare System, Spartanburg

32224

RECRUITING

Mayo Clinic, Jacksonville

33612

RECRUITING

Moffitt Cancer Center, Tampa

55905

RECRUITING

Mayo Clinic, Rochester

60611

RECRUITING

Northwestern University, Chicago

90813

RECRUITING

City of Hope, Huntington Beach

RECRUITING

City of Hope, Long Beach

91010

RECRUITING

City of Hope, Duarte

92618

RECRUITING

City of Hope, Irvine

94122

RECRUITING

University of California, San Francisco, San Francisco

06510

RECRUITING

Yale Cancer Center, New Haven

02215

RECRUITING

Dana Farber Cancer Institute, Boston

Unknown

RECRUITING

Chris O'Brien Lifehouse, Camperdown

RECRUITING

Peter MacCallum Cancer Centre, Melbourne

RECRUITING

One Clinical Research, Hollywood Medical Centre, Nedlands

RECRUITING

Sydney Adventist Health, Sydney

RECRUITING

The Chinese University of Hong Kong, Shatin

RECRUITING

Sultan Ahmad Shah Medical Centre at International Islamic University Malaysia (IIUM), Kuantan

RECRUITING

Pulau Pinang Hospital, George Town

RECRUITING

Sarawak General Hospital (SGH), Kuching

RECRUITING

Hospital Kuala Lumpur, Kuala Lumpur

RECRUITING

University of Malaya Medical Center (UMMC), Kuala Lumpur

RECRUITING

Medical University of Gdańsk, Gdansk

RECRUITING

Chungbuk University Hospital, Cheongju-si

RECRUITING

National Cancer Center, Goyang-si

RECRUITING

Catholic University of Korea, St, Vincent Hospital, Gyeonggi-do

RECRUITING

Gachon University Hospital, Incheon

RECRUITING

Seoul National Bundang Hospital, Seongnam-si

RECRUITING

Asan Medical Center, Seoul

RECRUITING

Samsung Medical Center, Seoul

RECRUITING

Severance Hospital, Yonsei University Health System, Seoul

RECRUITING

NEXT Oncology - Barcelona, Barcelona

RECRUITING

Vall d'Hebron Institute of Oncology (VHIO), Barcelona

RECRUITING

NEXT Oncology - Madrid, Madrid

RECRUITING

National Taiwan University Hospital, Taipei

RECRUITING

The Christie NHS Foundation Trust, Manchester

M5G 2C4

RECRUITING

Princess Margaret Cancer Centre, Toronto

Sponsors
All Listed Sponsors
lead

ORIC Pharmaceuticals

INDUSTRY